Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2005
11/16/2005EP1363608B1 Formulations comprising ibuprofen and diphenhydramine and the use thereof for the treatment of sleep disturbances
11/16/2005EP1341522B1 Microparticles with an improved release profile and method for the production thereof
11/16/2005EP1305378B1 Medical contact adhesive comprising a two phase adhesive matrix of polyacrylates and polyamine salts
11/16/2005EP1299085B1 Improved liposomal camptothecins and uses thereof
11/16/2005EP1299084B1 Liposomal antineoplastic drugs and uses thereof
11/16/2005EP1289517B1 Pharmaceutical compositions comprising cannabidiol derivatives
11/16/2005EP1274459B1 Sustained release formulations comprising growth hormone
11/16/2005EP1239824B1 Scar treatment composition comprising a silicone mixture
11/16/2005EP1237543B1 Effervescent histamine h2 antagonist composition
11/16/2005EP1220663B1 Superficial therapeutic system for topically applying acetylsalicylic acid, for the treatment of acne-related diseases
11/16/2005EP1220661B1 Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid
11/16/2005EP1216053B1 Influenza vaccine
11/16/2005EP1214043B1 Cosmetic and/or pharmaceutical preparations
11/16/2005EP1212097B1 Enzyme inhibitors
11/16/2005EP1146857B1 Materials and methods for making improved micelle compositions
11/16/2005EP1109837B1 Method for producing ultra-pure alginates
11/16/2005EP0904099B1 Pharmaceutical formulation containing human growth hormone, histidine and a non-ionic detergent
11/16/2005CN1697879A Biomolecule transfer method using virus envelope and composition and system therefor
11/16/2005CN1697663A Antitumor agent and process for producing the same
11/16/2005CN1697662A Water-in-oil emulsions with ethylene oxide groups, compositions, and methods
11/16/2005CN1697656A Phentanyl-containing adhesive patch for application to oral-cavity mucosa
11/16/2005CN1697653A Particulate product comprising pantethine
11/16/2005CN1697652A Adhesive patch containing tulobuterol
11/16/2005CN1697647A Liquor and method for restraining ache, inflammation and cartilage degradation
11/16/2005CN1697644A Materials and methods for preventing and treating microbe-mediated epithelial disorders
11/16/2005CN1695740A Composite body of fiber protein adhesive and antibiotics in use for treating infection in deep part, and application
11/16/2005CN1695739A Continuing release recipe of containing infusible basic remedy
11/16/2005CN1227258C Use of azalide antibiotic compositions for treating or preventing bacterial or protozoal infection in mammals
11/16/2005CN1227035C Conjugates and method for production thereof, and their use for transporting molecules via biological membranes
11/16/2005CN1227034C Process for producing drug complexes
11/16/2005CN1227025C Improved methods for processing activated protein C
11/16/2005CN1227012C Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
11/16/2005CN1227009C Pharmaceutical composition containing porton pump inhibitors
11/16/2005CN1227005C Nimesulide containing topical pharmaceutical compositions
11/16/2005CN1227004C Partial fatty acid oxidation inhibitors in treatment of congestive heart failure
11/16/2005CN1227003C Dosage form comprising liquid formulation
11/16/2005CN1227002C Active content contained floating form having polyacetic vinylester and polyvinyl pyrrolidone, its preparation and use
11/16/2005CN1227000C Using W/O emulsions as thickeners in cosmetic and pharmaceutical formulations
11/16/2005CN1226999C Solubilized pharmaceutical composition for parenteral administration
11/16/2005CN1226982C Oil-in-water emulsion comprising micronised biologically active agent and appropriate emulsified system
11/15/2005US6965049 Zwitterionic lipid compound and uses thereof
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005US6964946 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
11/15/2005US6964849 Proteins and nucleic acids encoding same
11/15/2005US6964783 Non-solid composition for local application
11/15/2005US6964782 Stable hydrogen peroxide compositions, products and methods of use
11/15/2005US6964781 For delivering drug directly to the interior portions of the body of a mammalian organism, such as to the eye
11/15/2005US6964780 Phosphodiesterase inhibitor; therapy for sexual disorders; sildenafil in polyoxyethylene glycol enteric coating
11/15/2005US6964777 An antianxiety agent such as buspirone; a dermal penetration enhancer of given formula such as octyl salicylate; and a volatile liquid such as ethanol
11/15/2005US6964764 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
11/15/2005CA2352190C Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith
11/15/2005CA2343148C Quick release pharmaceutical compositions of drug substances
11/15/2005CA2179419C Sulfated polyvinyl alcohol polymers to stabilize pharmaceutical drug compounds
11/15/2005CA2092346C Protein stabilised oil-in-water emulsions
11/14/2005CA2467321A1 Polymeric coupling agents and pharmaceutically-active polymers made therefrom
11/10/2005WO2005106046A1 Modified viral vector particles
11/10/2005WO2005105978A2 Drying process for preserving an active agent as a highly viscous liquid
11/10/2005WO2005105906A1 Embolization
11/10/2005WO2005105886A1 Low molecular weight polylactic acid polymers
11/10/2005WO2005105853A1 β-CHITIN COMPOSITE AND PROCESS FOR PRODUCING THE SAME
11/10/2005WO2005105214A1 Compositions comprising water-insoluble fullerenes and their use for preventing damages caused by free radicals
11/10/2005WO2005105154A1 Polymer conjugate releasable under mild thiolytic conditions
11/10/2005WO2005105153A1 Hydroxyalkyl derivatives of biologically active compounds
11/10/2005WO2005105152A2 Lipids, lipid complexes and use thereof
11/10/2005WO2005105151A1 Pegylated thymosin 1 derivatives
11/10/2005WO2005105150A1 Adhesive material
11/10/2005WO2005105149A1 Novel pharmaceutical or cosmetic carriers containing cylcic acetals
11/10/2005WO2005105148A2 Liquid growth hormone formulation
11/10/2005WO2005105141A2 Combined meningococcal conjugates with common carrier protein
11/10/2005WO2005105140A2 Meningococcal conjugate vaccination
11/10/2005WO2005105102A1 Improved nsaid composition
11/10/2005WO2005105070A2 Therapeutic antimicrobial compositions and methods
11/10/2005WO2005105067A2 Aqueous solutions comprising prednisolone and a cyclodextrin derivative
11/10/2005WO2005105060A1 Plaster
11/10/2005WO2005105059A1 Permeation enhancer comprising genus curcuma or germacrone for transdermal and topical administration of active agents
11/10/2005WO2005105058A1 Sustained-releasing injectable formulation for the treatment or prevention of bone-related diseases comprising bisphorenate-containing polymeric microparticles
11/10/2005WO2005105057A1 Sustained release formulations
11/10/2005WO2005105050A1 Oral formulation for delivery of poorly absorbed drugs
11/10/2005WO2005105048A1 Process for the selective increase of a release rate of an active material from a pharmaceutical composition
11/10/2005WO2005105047A1 Orally disintegrating tablet and method of preparation
11/10/2005WO2005105045A1 Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition
11/10/2005WO2005105044A1 Process for making inclusion complex of sulfonylureas having improved aqueous solubility
11/10/2005WO2005105041A2 Methods of enhancing solubility in water of hydrophobic compounds by micellar dispersions
11/10/2005WO2005105037A2 Use of a viscoelastic composition for treating increased intraocular pressure
11/10/2005WO2005105035A2 Targeted nanoparticles for drug delivery
11/10/2005WO2005105034A1 Dermally applicable liquid formulations for controlling parasitic arthropods on animals
11/10/2005WO2005104712A2 Dpi formulation containing sulfoalkyl ether cyclodextrin
11/10/2005WO2005104648A2 Pegylated nanoparticles
11/10/2005WO2005089503A3 Cd4-igg2 formulations
11/10/2005WO2005077338A8 Particles for inhalation rapid release properties
11/10/2005WO2005076975A3 Complexed polypeptide and adjuvant for improved vaccines
11/10/2005WO2005066348A3 Interleukin-12 targeted to oncofoetal fibronectin
11/10/2005WO2005042600A3 High molecular weight polymers, devices and method for making and using same
11/10/2005WO2005042142A3 Thermosensitive, biocompatible polymer carriers with a variable physical structure for treatment, diagnosis and analysis
11/10/2005WO2005041924A3 Administration of levodopa and carbidopa
11/10/2005WO2005030259A3 Nucleic acid-lipophilic conjugates
11/10/2005WO2005025592A3 In vivo modulation of neuronal transport
11/10/2005WO2004100983A3 Treatment of lupus targeting the macrophages or the folate receptor
11/10/2005WO2004091666A8 Compositions containing piperacillin and tazobactam useful for injection
11/10/2005WO2004087121A8 Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases
1 ... 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 ... 1712